Comparing Pluri (NASDAQ:PLUR) and Halozyme Therapeutics (NASDAQ:HALO)
Pluri (NASDAQ:PLUR – Get Free Report) and Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Earnings and Valuation This table compares Pluri and Halozyme […]
More Stories
Stryker Co. (NYSE:SYK) Plans $0.80 Quarterly Dividend
Stryker Co. (NYSE:SYK – Get Free Report) announced a quarterly dividend on Wednesday, August 7th, Wall Street Journal reports. Stockholders...
Arteris, Inc. (NASDAQ:AIP) Short Interest Down 19.8% in September
Arteris, Inc. (NASDAQ:AIP – Get Free Report) was the recipient of a significant decline in short interest in the month...
Agrify Co. (NASDAQ:AGFY) Short Interest Down 28.8% in September
Agrify Co. (NASDAQ:AGFY – Get Free Report) was the recipient of a large drop in short interest in the month...
BlackBerry (NYSE:BB) Releases FY25 Earnings Guidance
BlackBerry (NYSE:BB – Get Free Report) updated its FY25 earnings guidance on Thursday. The company provided earnings per share (EPS)...
Bloom Energy Co. (NYSE:BE) Receives Consensus Rating of “Hold” from Brokerages
Shares of Bloom Energy Co. (NYSE:BE – Get Free Report) have earned an average recommendation of “Hold” from the twenty...
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 27.7% in September
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a significant increase in short interest in the...